Document Detail


Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt.
MedLine Citation:
PMID:  19079291     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: NYGGF4 is a novel gene that is abundantly expressed in the adipose tissue of obese patients. The purpose of this study was to investigate the effects of NYGGF4 on basal and insulin-stimulated glucose uptake in mature 3T3-L1 adipocytes and to understand the underlying mechanisms. METHODS: 3T3-L1 preadipocytes transfected with either an empty expression vector (pcDNA3.1Myc/His B) or an NYGGF4 expression vector were differentiated into mature adipocytes. Glucose uptake was determined by measuring 2-deoxy-D-[3H]glucose uptake into the adipocytes. Immunoblotting was performed to detect the translocation of insulin-sensitive glucose transporter 4 (GLUT4). Immunoblotting also was used to measure the phosphorylation and total protein contents of insulin signaling proteins such as the insulin receptor (IR), insulin receptor substrate (IRS)-1, Akt, ERK1/2, p38, and JNK. RESULTS: NYGGF4 over-expression in 3T3-L1 adipocytes reduced insulin-stimulated glucose uptake and impaired insulin-stimulated GLUT4 translocation. It also diminished insulin-stimulated tyrosine phosphorylation of IRS-1 and serine phosphorylation of Akt without affecting the phosphorylation of IR, ERK1/2, p38, and JNK. CONCLUSION: NYGGF4 regulates the functions of IRS-1 and Akt, decreases GLUT4 translocation and reduces glucose uptake in response to insulin. These observations highlight the potential role of NYGGF4 in glucose homeostasis and possibly in the pathogenesis of obesity.
Authors:
Chun-mei Zhang; Xiao-hui Chen; Bin Wang; Feng Liu; Xia Chi; Mei-ling Tong; Yu-hui Ni; Rong-hua Chen; Xi-rong Guo
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-12-15
Journal Detail:
Title:  Acta pharmacologica Sinica     Volume:  30     ISSN:  1745-7254     ISO Abbreviation:  Acta Pharmacol. Sin.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-06     Completed Date:  2009-04-21     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  100956087     Medline TA:  Acta Pharmacol Sin     Country:  China    
Other Details:
Languages:  eng     Pagination:  120-4     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Nanjing Maternal and Child Health Hospital of Nanjing Medical University, Nanjing 210004, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3T3-L1 Cells / metabolism*
Animals
Carrier Proteins / genetics,  metabolism*
Glucose / metabolism*
Glucose Transporter Type 4 / genetics,  metabolism
Humans
Insulin / metabolism
Insulin Receptor Substrate Proteins / genetics,  metabolism
Mice
Proto-Oncogene Proteins c-akt / genetics,  metabolism
Signal Transduction / physiology
Chemical
Reg. No./Substance:
0/Carrier Proteins; 0/Glucose Transporter Type 4; 0/Insulin Receptor Substrate Proteins; 0/Irs1 protein, mouse; 0/PID1 protein, human; 11061-68-0/Insulin; 50-99-7/Glucose; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hydrogen peroxide mobilizes Ca2+ through two distinct mechanisms in rat hepatocytes.
Next Document:  Transformation and action of extracellular NAD+ in perfused rat and mouse livers.